How did AMB come to be? Anthony Hessel and Khoi Nguyen, who now work together at AMB, initially did not know each other. Anthony was conducting academic research using a synchrotron facility in the U.S., but when it closed for upgrades, he moved to a facility in Hamburg, Germany. There, he began exploring the idea of creating a mail-in service for X-raybased muscle research after a suggestion from a local lab leader and encouragement from others. To pursue the idea, Anthony posted on Twitter seeking collaborators. Khoi, then finishing his postdoc in MRI imaging and debating between staying in academia or finding other opportunities, saw the post through his PhD advisor, who happened to be friends with Anthonys advisor. That connection led Khoi to reach out. What began as a plan to build simple analysis software evolved into a much broader initiativea contract research organization. Their partnership was sparked by that tweet, mutual scientific interests, and even a shared fondness for Pokmon (especially Bulbasaur). What is the goal of AMB, and what sets it apart from other CROs? Anthony and Khoi share a vision for Accelerated Muscle Biotechnologies (AMB) that centers on expanding access to advanced muscle research tools. Khoi emphasizes his desire to bridge the gap between scientific discovery and real-world impact, turning niche technologieslike X-raybased muscle analysisinto methods widely used for diagnosing and treating muscle diseases. Anthony builds on this idea, describing AMB as a multidisciplinary organization that integrates X-ray diffraction with other muscle research techniques. He envisions a future where such specialized tools are centralized and accessible, much like how researchers outsource proteomics today. Together, they see AMB as a way to democratize complex technologies, empowering more scientists to explore, understand, and ultimately improve human muscle health. At Accelerated Muscle Biotechnologies (AMB), the team fosters a culture that keeps scientific curiosity at the center of their work. Rather than separating industry and academic research, AMB encourages its scientists to pursue their own independent projects, collaborate externally, and even apply for traditional research funding like NIH grants. This approach allows employees to remain active contributors to the broader scientific community through publishing and conferences, while still advancing company goals. This model gives researchers the flexibility to support both their professional and personal scientific interestswhether directly related to AMBs focus or not. Ultimately, both founders emphasize that AMB is built on the principle of being scientists first, creating an environment where meaningful, curiosity-driven research can thrive alongside commercial work. The Aurora Scientific and AMB Partnership The partnership between Accelerated Muscle Biotechnologies (AMB) and Aurora Scientific was born out of shared values around scientific rigor and standardization. Chris Rand, from Aurora Scientific, has known Anthony Hessel for years and admired his passion for doing high-quality, reproducible sciencean approach that aligns closely with Auroras mission to promote standardized, reliable methodologies through well-designed instrumentation. When Anthony and Khoi approached Aurora in late 2024, the two teams quickly recognized their complementary strengths. AMB brought creative ideas for improving experimental techniques and expanding access to consistent muscle research methods, while Aurora had the expertise and tools to make those ideas tangible. Anthony emphasized that AMB isnt a manufacturing company but thrives on collaborationsharing ideas freely with partners like Aurora to develop innovative solutions that can advance and unify the field. The partnership has since grown into a productive collaboration, focused on building tools and standards that empower researchers to achieve higher-quality, more reproducible results across laboratories worldwide. What will the AMB Aurora partnership provide to the muscle and XRD space? The partnership is focused on advancing the tools and methods used in muscle mechanics and X-ray diffraction (XRD) research. Together, the teams aim to develop a new generation of equipment that leverages modern software and technology to make experiments faster, more consistent, and more reproduciblewithout compromising scientific rigor. Beyond improving precision, the collaboration seeks to address common barriers in the field, such as high costs, low throughput, and steep learning curves. By combining AMBs research expertise with Auroras broad experience and direct feedback from hundreds of laboratories, theyre working to simplify complex techniques and make high-quality experimentation more accessible across the scientific community. A key goal is to make muscle XRD technology more accessibleturning it from something only specialized labs can perform into a process that any well-equipped muscle research lab can adopt through commercially available, user-friendly solutions. While these innovations wont eliminate the need for skilled scientists, they promise to reduce variability, minimize experimental error, and solve long-standing technical frustrations that researchers have faced for decades. Ultimately, the AMBAurora partnership is about driving practical innovationtranslating creative problem-solving and technological advances into tools that elevate the entire muscle research field.